{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T05:04:53Z","timestamp":1773378293470,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T00:00:00Z","timestamp":1733961600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C64263\/A29365"],"award-info":[{"award-number":["C64263\/A29365"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinical-colorectal-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Colorectal Cancer"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.clcc.2024.12.001","type":"journal-article","created":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T01:55:07Z","timestamp":1733968507000},"page":"166-179","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Oncological Outcomes From Cytoreductive Surgery and Heated Intraperitoneal Chemotherapy for Colorectal Cancer Peritoneal Metastases"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1877-658X","authenticated-orcid":false,"given":"Nadina","family":"Tinsley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah T.","family":"O'Dwyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6891-5181","authenticated-orcid":false,"given":"Raghavendar","family":"Nagaraju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6666-4868","authenticated-orcid":false,"given":"Michael","family":"Braun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saifee","family":"Mullamitha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3506-1500","authenticated-orcid":false,"given":"Konstantinos","family":"Kamposioras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.E. Marti","family":"Marti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Saunders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamish","family":"Clouston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chelliah","family":"Selvasekar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Wild","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malcolm","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Renehan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omer","family":"Aziz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Barriuso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clcc.2024.12.001_bib0001","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.650098","article-title":"Peritoneal metastases from colorectal cancer: defining and addressing the challenges","volume":"11","author":"Kranenburg","year":"2021","journal-title":"Front Oncol"},{"issue":"27","key":"10.1016\/j.clcc.2024.12.001_bib0002","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.3748\/wjg.v25.i27.3484","article-title":"Colorectal peritoneal metastases: optimal management review","volume":"25","author":"S\u00e1nchez-Hidalgo","year":"2019","journal-title":"World J Gastroenterol"},{"issue":"March","key":"10.1016\/j.clcc.2024.12.001_bib0003","first-page":"1","article-title":"Peritoneal metastases from colorectal cancer: defining and addressing the challenges","volume":"11","author":"Kranenburg","year":"2021","journal-title":"Front Oncol"},{"issue":"2","key":"10.1016\/j.clcc.2024.12.001_bib0004","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/(SICI)1097-0142(20000115)88:2<358::AID-CNCR16>3.0.CO;2-O","article-title":"Peritoneal carcinomatosis from non-gynecologic malignancies","volume":"88","author":"Sadeghi","year":"2000","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.clcc.2024.12.001_bib0005","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/S1470-2045(16)30500-9","article-title":"Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database","volume":"17","author":"Franko","year":"2016","journal-title":"Lancet Oncol"},{"issue":"9582","key":"10.1016\/j.clcc.2024.12.001_bib0006","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0140-6736(07)61086-1","article-title":"Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomised controlled trial","volume":"370","author":"Koopman","year":"2007","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.clcc.2024.12.001_bib0007","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1200\/JCO.2011.37.1039","article-title":"Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of North Central Cancer Treatment Group Phase III trials N9741 and N9841","volume":"30","author":"Franko","year":"2012","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.clcc.2024.12.001_bib0008","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S1470-2045(20)30599-4","article-title":"Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial","volume":"22","author":"Qu\u00e9net","year":"2021","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.clcc.2024.12.001_bib0009","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.annonc.2022.10.003","article-title":"Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up\u2020","volume":"34","author":"Cervantes","year":"2022","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.clcc.2024.12.001_bib0010","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1200\/JCO.22.01690","article-title":"Treatment of metastatic colorectal cancer: ASCO guideline","volume":"41","author":"Morris","year":"2023","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.clcc.2024.12.001_bib0011","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1186\/s12885-022-09572-7","article-title":"GECOP-MMC: phase IV randomized clinical trial to evaluate the efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC) with mytomicin-C after complete surgical cytoreduction in patients with colon cancer peritoneal metastases","volume":"22","author":"Pereira","year":"2022","journal-title":"BMC Cancer"},{"issue":"11","key":"10.1016\/j.clcc.2024.12.001_bib0012","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1016\/j.ejso.2021.05.023","article-title":"The impact of PRODIGE 7 on the current worldwide practice of CRS-HIPEC for colorectal peritoneal metastases: A web-based survey and 2021 statement by Peritoneal Surface Oncology Group International (PSOGI)","volume":"47","author":"van de Vlasakker","year":"2021","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"10.1016\/j.clcc.2024.12.001_bib0013","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.ejso.2018.10.542","article-title":"HIPEC with oxaliplatin for colorectal peritoneal metastasis: the end of the road?","volume":"45","author":"Ceelen","year":"2019","journal-title":"Eur J Surg Oncol"},{"issue":"10","key":"10.1016\/j.clcc.2024.12.001_bib0014","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S2468-1253(19)30239-0","article-title":"Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial","volume":"4","author":"Klaver","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.clcc.2024.12.001_bib0015","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S1470-2045(20)30322-3","article-title":"Second-look surgery plus hyperthermic intraperitoneal chemotherapy versus surveillance in patients at high risk of developing colorectal peritoneal metastases (PROPHYLOCHIP-PRODIGE 15): a randomised, phase 3 study","volume":"21","author":"Go\u00e9r\u00e9","year":"2020","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.clcc.2024.12.001_bib0016","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ejso.2022.07.019","article-title":"Patterns and timing of recurrence following CRS and HIPEC in colorectal cancer peritoneal metastasis","volume":"49","author":"Hassan","year":"2023","journal-title":"Eur J Surg Oncol"},{"issue":"11","key":"10.1016\/j.clcc.2024.12.001_bib0017","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1038\/nm.3967","article-title":"The consensus molecular subtypes of colorectal cancer","volume":"21","author":"Guinney","year":"2015","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.clcc.2024.12.001_bib0018","doi-asserted-by":"crossref","first-page":"4443","DOI":"10.1038\/s41467-022-32198-z","article-title":"Molecular characterization of colorectal cancer related peritoneal metastatic disease","volume":"13","author":"Lenos","year":"2022","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.clcc.2024.12.001_bib0019","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/jnci\/djab106","article-title":"Clinical value of consensus molecular subtypes in colorectal cancer: a systematic review and meta-analysis","volume":"114","author":"ten Hoorn","year":"2022","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"10.1016\/j.clcc.2024.12.001_bib0020","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/bcp.13773","article-title":"Hyperthermic intraperitoneal chemotherapy with oxaliplatin for peritoneal carcinomatosis: a clinical pharmacological perspective on a surgical procedure","volume":"85","author":"de Jong","year":"2019","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.clcc.2024.12.001_sbref0021","series-title":"IBM SPSS Statistics for Windows, Version 28.0","year":"2021"},{"key":"10.1016\/j.clcc.2024.12.001_sbref0022","series-title":"R: a Language and Environment for Statistical Computing","year":"2020"},{"issue":"5","key":"10.1016\/j.clcc.2024.12.001_bib0023","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/s41416-021-01620-6","article-title":"Impact of KRAS, BRAF and microsatellite instability status after cytoreductive surgery and HIPEC in a national cohort of colorectal peritoneal metastasis patients","volume":"126","author":"Larsen","year":"2022","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.clcc.2024.12.001_bib0024","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1245\/s10434-019-07452-2","article-title":"Prognostic impact of BRAF and KRAS mutation in patients with colorectal and appendiceal peritoneal metastases scheduled for CRS and HIPEC","volume":"27","author":"Graf","year":"2020","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.clcc.2024.12.001_bib0025","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1245\/s10434-017-6141-7","article-title":"Impact of RAS mutations in metastatic colorectal cancer after potentially curative resection: does site of metastases matter?","volume":"25","author":"Passot","year":"2018","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.clcc.2024.12.001_bib0026","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/COC.0b013e3181b4b160","article-title":"KRAS status in patients with colorectal cancer peritoneal carcinomatosis and its impact on outcome","volume":"33","author":"Gillern","year":"2010","journal-title":"Am J Clin Oncol"},{"issue":"12","key":"10.1016\/j.clcc.2024.12.001_bib0027","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1016\/j.ejso.2019.07.008","article-title":"European Journal of Surgical Oncology Referral pathways and outcome of patients with colorectal peritoneal metastasis (CRPM)","volume":"45","author":"Larentzakis","year":"2019","journal-title":"Eur J Surg Oncol"},{"issue":"9","key":"10.1016\/j.clcc.2024.12.001_bib0028","doi-asserted-by":"crossref","first-page":"106924","DOI":"10.1016\/j.ejso.2023.04.023","article-title":"Open versus closed technique for administration of heated intraperitoneal chemotherapy (HIPEC): morbidity and mortality outcomes from a high-volume centre","volume":"49","author":"Hassan","year":"2023","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"10.1016\/j.clcc.2024.12.001_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2023.107931","article-title":"Oncological outcomes and hospitalization cost of hyperthermic intraperitoneal chemotherapy (HIPEC) open and closed abdomen techniques: results from two French expert centers","volume":"50","author":"Ezanno","year":"2024","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.clcc.2024.12.001_bib0030","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12957-019-1618-4","article-title":"Peritoneal carcinomatosis index predicts survival in colorectal patients undergoing HIPEC using oxaliplatin\u202f: a retrospective single-arm cohort study","volume":"17","author":"Burnett","year":"2019","journal-title":"World J Surg Oncol"},{"issue":"Suppl 1","key":"10.1016\/j.clcc.2024.12.001_bib0031","doi-asserted-by":"crossref","first-page":"S191","DOI":"10.21037\/jgo-20-136","article-title":"Omics analyses in peritoneal metastasis-utility in the management of peritoneal metastases from colorectal cancer and pseudomyxoma peritonei: a narrative review","volume":"12","author":"Lund-Andersen","year":"2021","journal-title":"J Gastrointest Oncol"},{"issue":"5","key":"10.1016\/j.clcc.2024.12.001_bib0032","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-039314","volume":"10","author":"Gurusamy","year":"2020","journal-title":"BMJ Open"}],"container-title":["Clinical Colorectal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002824001154?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002824001154?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T01:21:13Z","timestamp":1769044873000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1533002824001154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S1533002824001154"],"URL":"https:\/\/doi.org\/10.1016\/j.clcc.2024.12.001","relation":{},"ISSN":["1533-0028"],"issn-type":[{"value":"1533-0028","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oncological Outcomes From Cytoreductive Surgery and Heated Intraperitoneal Chemotherapy for Colorectal Cancer Peritoneal Metastases","name":"articletitle","label":"Article Title"},{"value":"Clinical Colorectal Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clcc.2024.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}